Page last updated: 2024-08-18

arginine vasopressin and Huntington Disease

arginine vasopressin has been researched along with Huntington Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Colwell, CS; Gad, L; Ghiani, CA; Hitchcock, ON; Kuljis, DA; Loh, DH; MacDowell Kaswan, Z1
Anink, JJ; Aziz, NA; Roos, RA; Swaab, DF; van Wamelen, DJ1
Angeloni, D; Anink, JJ; Aziz, NA; Fraschini, F; Jockers, R; Roos, RA; Swaab, DF; van Steenhoven, R; van Wamelen, DJ1

Other Studies

3 other study(ies) available for arginine vasopressin and Huntington Disease

ArticleYear
Sex Differences in Circadian Dysfunction in the BACHD Mouse Model of Huntington's Disease.
    PloS one, 2016, Volume: 11, Issue:2

    Topics: Animals; Arginine Vasopressin; Chromosomes, Artificial, Bacterial; Circadian Rhythm; Disease Models, Animal; Disease Progression; Female; Founder Effect; Gene Expression; Humans; Huntington Disease; Male; Mice; Mice, Transgenic; Motor Activity; Rotarod Performance Test; Sex Factors; Suprachiasmatic Nucleus; Time Factors; Vasoactive Intestinal Peptide

2016
Paraventricular nucleus neuropeptide expression in Huntington's disease patients.
    Brain pathology (Zurich, Switzerland), 2012, Volume: 22, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Arginine Vasopressin; Corticotropin-Releasing Hormone; Female; Humans; Huntington Disease; Male; Middle Aged; Nerve Tissue Proteins; Neurons; Neuropeptides; Oxytocin; Paraventricular Hypothalamic Nucleus; RNA, Messenger; Statistics, Nonparametric

2012
Suprachiasmatic nucleus neuropeptide expression in patients with Huntington's Disease.
    Sleep, 2013, Jan-01, Volume: 36, Issue:1

    Topics: Arginine Vasopressin; Chronobiology Disorders; Circadian Rhythm; Cohort Studies; Female; Humans; Huntington Disease; Hypothalamus; In Situ Hybridization; Male; Neuropeptides; Sleep Wake Disorders; Suprachiasmatic Nucleus; Vasoactive Intestinal Peptide

2013